Ohio Reaches $18.325 Million Settlement in Drug Pricing Lawsuit

Ohio has reached an $18.325 million settlement in a lawsuit brought against McKesson Corporation (McKesson) for an alleged scheme to inflate the price of drugs prescribed for beneficiaries of the Ohio Public Employees Retirement System (OPERS), State Teachers Retirement System of Ohio (STRS Ohio), and the Ohio Bureau of Workers’ Compensation (BWC).

McKesson is a San Francisco-based pharmaceutical and medical products distribution company and is one of the largest wholesalers in the country. The lawsuit, filed in May 2013, accused the company of a conspiracy to inflate average wholesale prices of hundreds of brand-name drugs that are used by OPERS, STRS Ohio, and the BWC to set prescription drug reimbursement rates.

Ali Abtahi served as local counsel for the Ohio in prosecution of the lawsuit against McKesson.